Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Release Date:
Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia